Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Einari Aavik

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Atherosclerosis|December 29, 2018
DNA methylation processes in atheosclerotic plaqueEinari Aavik, Mohan Babu, Seppo Ylä-Herttuala
Biochimica Et Biophysica Acta|February 24, 2009
Epigenetics and atherosclerosisMikko P Turunen, Einari Aavik, Seppo Ylä-Herttuala
Current Opinion in Lipidology|July 23, 2013
Epigenetic regulation in vascular cellsMikko P Turunen, Einari Aavik, Seppo Ylä-Herttuala
Frontiers in Genetics|August 23, 2021
Epigenetic Regulation of Vascular Smooth Muscle Cell Phenotype Switching in Atherosclerotic Artery Remodeling: A Mini-ReviewMichelle Zurek, Einari Aavik, Rahul Mallick, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Chronic rejection: prospects for therapeutic intervention in fibroproliferative vascular diseasePekka Häyry, Einari Aavik, Minnie Sarwal, et al.
Molecular and Cellular Endocrinology|October 20, 2007
Vasculoprotective effects of somatostatin receptor subtypesNina-Maria Tigerstedt, Einari Aavik, Silja Aavik, et al.
Journal of Vascular Research|November 6, 2008
Mechanisms behind the synergistic effect of sirolimus and imatinib in preventing restenosis after intimal injuryNina-Maria Tigerstedt, Einari Aavik, Satu Lehti, et al.
Journal of Vascular Research|January 18, 2006
Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosisJoannis E Vamvakopoulos, Lyubomir Petrov, Silja Aavik, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2002
Elimination of vascular fibrointimal hyperplasia by somatostatin receptor 1,4-selective agonistEinari Aavik, Nina-Maria Luoto, Lubomir Petrov, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 17, 2022
ApoA-I Nanotherapy Rescues Postischemic Vascular Maladaptation by Modulating Endothelial Cell and Macrophage Phenotypes in Type 2 Diabetic MiceMohan Babu, Durga Devi, Petri Mäkinen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Atherosclerosis|December 29, 2018
DNA methylation processes in atheosclerotic plaqueEinari Aavik, Mohan Babu, Seppo Ylä-Herttuala
Biochimica Et Biophysica Acta|February 24, 2009
Epigenetics and atherosclerosisMikko P Turunen, Einari Aavik, Seppo Ylä-Herttuala
Current Opinion in Lipidology|July 23, 2013
Epigenetic regulation in vascular cellsMikko P Turunen, Einari Aavik, Seppo Ylä-Herttuala
Frontiers in Genetics|August 23, 2021
Epigenetic Regulation of Vascular Smooth Muscle Cell Phenotype Switching in Atherosclerotic Artery Remodeling: A Mini-ReviewMichelle Zurek, Einari Aavik, Rahul Mallick, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|April 30, 2005
Chronic rejection: prospects for therapeutic intervention in fibroproliferative vascular diseasePekka Häyry, Einari Aavik, Minnie Sarwal, et al.
Molecular and Cellular Endocrinology|October 20, 2007
Vasculoprotective effects of somatostatin receptor subtypesNina-Maria Tigerstedt, Einari Aavik, Silja Aavik, et al.
Journal of Vascular Research|November 6, 2008
Mechanisms behind the synergistic effect of sirolimus and imatinib in preventing restenosis after intimal injuryNina-Maria Tigerstedt, Einari Aavik, Satu Lehti, et al.
Journal of Vascular Research|January 18, 2006
Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosisJoannis E Vamvakopoulos, Lyubomir Petrov, Silja Aavik, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 30, 2002
Elimination of vascular fibrointimal hyperplasia by somatostatin receptor 1,4-selective agonistEinari Aavik, Nina-Maria Luoto, Lubomir Petrov, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 17, 2022
ApoA-I Nanotherapy Rescues Postischemic Vascular Maladaptation by Modulating Endothelial Cell and Macrophage Phenotypes in Type 2 Diabetic MiceMohan Babu, Durga Devi, Petri Mäkinen, et al.
Pageof 3